Peter Avalos

National Reimbursement Director at Daiichi Sankyo, Inc.

Speaker

Peter Avalos joined Geron in December 2022 from Daiichi Sankyo Inc., where he established a field reimbursement model and hub infrastructure to ensure visibility to key data and metrics to execute a successful launch of the antibody drug conjugate, Enhertu, into the U.S. market. Mr. Avalos has over twenty-five years of experience working in the healthcare industry across both the drug and medical device sectors. His deep experience includes building and executing patient engagement models, group purchasing organizations (GPO), trade and patient access, as well as roles across many disciplines, including accounting and finance, sales leadership, pricing and strategy. Previous company experiences include Walgreens Boots Alliance, Inc., Dendreon Pharmaceuticals LLC and Johnson & Johnson. Mr. Avalos holds multiple degrees from Seton Hall University, including a B.S. in Business Administration, an M.S. in International Business and an M.B.A.

As Vice President, Trade and Channel Relations, Mr. Avalos leads the development of imetelstat’s trade distribution, national accounts and GPO strategy, as well as the future hub and field reimbursement model to support potential commercial launch of imetelstat into the U.S. market.